Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04330716 · ClinicalTrials.gov registry record · NA
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 269
- Enrollment target
NCT04330716 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 269 participants.
The verdict
NCT04330716, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 269 participants
- Enrollment target
Study Summary
This study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.
Interventions
- BEHAVIORAL Educational Video
- BEHAVIORAL Standard Genetic Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04330716
The ClinicalTrials.gov registry entry for NCT04330716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 269 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Educational Video is the first listed.
NCT04330716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04330716 about?
NCT04330716 is a clinical study titled "Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers". This study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.
What is the current status of trial NCT04330716?
This trial is currently completed. It is a NA study. The enrollment target is 269 participants. The study started on 2020-12-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04330716?
The interventions under investigation include: Educational Video (BEHAVIORAL), Standard Genetic Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT04330716?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.